Identification of cellular determinants of responseto systemic treatment in triple-negative breast carcinomas

Introduction – Triple-negative breast cancer (TNBC) is a less common but more aggressive molecular subtype of breast cancer that is found particularly in younger patients. Although it has no specific therapeutic target, the discovery of its high immunogenicity has led to the development of new immun